|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Horizon Pharma, Inc. (HZNP) |
|
|
$28.30 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
211,410,000 |
| Market
Cap: |
5.98(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$28.3 - $28.3 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Horizon Therapeutics is focused on researching, developing and commercializing medicines that address the needs for people with rare and rheumatic diseases. Co. has two segments, the orphan segment and the inflammation segment. The Orphan segment includes: TEPEZZA, which is indicated for the treatment of thyroid eye diseas; KRYSTEXXA, which is indicated for the treatment of uncontrolled gout; and PROCYSBI, which is indicated for nephropathic cystinosis. The Inflammation segment includes: PENNSAID 2% w/w, which is indicated for the treatment of pain of osteoarthritis (OA), of the knee(s); and DUEXIS, which is indicated for the relief of signs and symptoms of rheumatoid arthritis and OA.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
745 |
| Total Buy Value |
$0 |
$0 |
$0 |
$49,669 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
215,235 |
| Total Sell Value |
$0 |
$0 |
$0 |
$22,329,250 |
| Total People Sold |
0 |
0 |
0 |
5 |
| Total Sell Transactions |
0 |
0 |
0 |
14 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Sherman Jeffrey W |
EVP and Chief Medical Officer |
• – – |
2021-06-11 |
4 |
GD |
$0.00 |
$0 |
I/I |
5,287 |
44,775 |
|
- |
|
| Mchugh Miles W |
Sr VP & Princ. Acctg Officer |
• – – |
2021-06-10 |
4 |
D |
$93.95 |
$138,764 |
D/D |
(1,477) |
36,521 |
|
- |
|
| Mchugh Miles W |
Sr VP & Princ. Acctg Officer |
• – – |
2021-06-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,334 |
37,998 |
|
- |
|
| Walbert Timothy P |
Chairman, President and CEO |
• • – |
2021-06-01 |
4 |
AS |
$91.00 |
$2,296,204 |
D/D |
(25,000) |
875,887 |
|
- |
|
| Sherman Jeffrey W |
EVP and Chief Medical Officer |
• – – |
2021-05-25 |
4 |
GA |
$0.00 |
$0 |
I/I |
12,304 |
50,062 |
|
- |
|
| Sherman Jeffrey W |
EVP and Chief Medical Officer |
• – – |
2021-05-25 |
4 |
GD |
$0.00 |
$0 |
D/D |
12,304 |
46,989 |
|
- |
|
| Hoelscher Paul W. |
EVP, CFO |
• – – |
2021-05-14 |
4 |
AS |
$90.01 |
$9,263,847 |
I/I |
(102,925) |
172,226 |
|
- |
|
| Kent Jeff |
See remarks |
• – – |
2021-05-11 |
4 |
OE |
$22.14 |
$278,787 |
D/D |
12,592 |
83,586 |
|
- |
|
| Daniel William F |
Director |
– • – |
2021-05-10 |
4 |
S |
$86.56 |
$1,731,275 |
D/D |
(20,000) |
0 |
|
- |
|
| Daniel William F |
Director |
– • – |
2021-05-10 |
4 |
OE |
$12.70 |
$254,000 |
D/D |
20,000 |
20,000 |
|
- |
|
| Santini Gino |
Director |
– • – |
2021-04-30 |
4 |
D |
$94.62 |
$412,259 |
I/I |
(4,357) |
46,249 |
|
- |
|
| Santini Gino |
Director |
– • – |
2021-04-30 |
4 |
OE |
$0.00 |
$0 |
I/I |
11,098 |
50,606 |
|
- |
|
| Shannon James Samuel |
Director |
– • – |
2021-04-30 |
4 |
D |
$94.62 |
$412,259 |
I/I |
(4,357) |
40,345 |
|
- |
|
| Shannon James Samuel |
Director |
– • – |
2021-04-30 |
4 |
OE |
$0.00 |
$0 |
I/I |
11,098 |
44,702 |
|
- |
|
| Witz Pascale |
Director |
– • – |
2021-04-30 |
4 |
D |
$94.62 |
$412,259 |
I/I |
(4,357) |
41,352 |
|
- |
|
| Witz Pascale |
Director |
– • – |
2021-04-30 |
4 |
OE |
$0.00 |
$0 |
I/I |
11,098 |
45,709 |
|
- |
|
| Grey Michael G |
Director |
– • – |
2021-04-30 |
4 |
D |
$94.62 |
$283,198 |
I/I |
(2,993) |
70,395 |
|
- |
|
| Grey Michael G |
Director |
– • – |
2021-04-30 |
4 |
OE |
$0.00 |
$0 |
I/I |
11,098 |
73,388 |
|
- |
|
| Himawan Jeff |
Director |
– • – |
2021-04-30 |
4 |
OE |
$0.00 |
$0 |
I/I |
11,098 |
53,979 |
|
- |
|
| Watkins Thomas |
Director |
– • – |
2021-04-30 |
4 |
OE |
$0.00 |
$0 |
I/I |
11,098 |
70,941 |
|
- |
|
| Walbert Timothy P |
Chairman, President and CEO |
• • – |
2021-04-30 |
4 |
AS |
$94.15 |
$2,374,413 |
D/D |
(25,000) |
899,838 |
|
- |
|
| Daniel William F |
Director |
– • – |
2021-04-30 |
4 |
D |
$94.62 |
$283,198 |
I/I |
(2,993) |
74,467 |
|
- |
|
| Daniel William F |
Director |
– • – |
2021-04-30 |
4 |
OE |
$0.00 |
$0 |
I/I |
11,098 |
77,460 |
|
- |
|
| Mahony Susan |
Director |
– • – |
2021-04-30 |
4 |
D |
$94.62 |
$412,259 |
I/I |
(4,357) |
14,052 |
|
- |
|
| Mahony Susan |
Director |
– • – |
2021-04-30 |
4 |
OE |
$0.00 |
$0 |
I/I |
11,098 |
18,409 |
|
- |
|
1030 Records found
|
|
Page 11 of 42 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
